You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

September 15, 2022

Thailand’s New Legal Framework for Kratom

Subscribe to Updates

In 2021, Thailand passed the updated Narcotics Act (No. 8) B.E. 2564 (2021), which removed kratom (Mitragyna speciosa) from the list of prohibited substances, eliminated kratom-related offenses on the basis that its consumption is part of traditional Thai cultural norms, and allowed possession and consumption.

On August 26, 2022, Thailand published the Kratom Plant Act B.E. 2565 (2022) in the Government Gazette, and the law came into effect the following day. With the aim of encouraging economic activity related to kratom, the act regulates the trade, sale, consumption, study, and advertising of kratom leaves (alone or as an ingredient in food) in Thailand.

Importing and Exporting Kratom Leaves

Importing and exporting kratom leaves without obtaining a license from the secretary-general of the Narcotics Control Board (NCB) is prohibited under the Kratom Plant Act. Eligible license recipients include:

  • Thai nationals over twenty years old and residing in Thailand;
  • Juristic persons registered under Thai law;
  • Community enterprises under the law; and
  • Government agencies.

A license is valid for five years, and importers and exporters must still notify the NCB when importing or exporting kratom leaves. An exception to the licensing requirement is bringing kratom leaves in and out of Thailand for personal consumption, therapy, and treatment of an illness. The amounts allowed for international travel are to be specified in ministerial regulations. If the amount of the kratom leaves exceeds this allowance, the transport will be considered importing or exporting of kratom leaves, triggering the licensing requirements described above.

Violation of these requirements is subject to imprisonment for up to one year, a maximum fine of THB 100,000, or both.

Selling Kratom

The Kratom Plant Act also allows the sale of kratom leaves alone or as an ingredient in food, subject to certain conditions. Under the law, sales of kratom include selling, dispensing, distributing, exchanging, or giving the substance to others. The laws measures pertaining to this are intended to protect people from the potential harm of consuming or misusing kratom.

It is prohibited to sell kratom leaves or food that contains kratom leaves as an ingredient to persons under 18 years old, and pregnant or breastfeeding women. The law also authorizes ministers of the Ministry of Justice and the Ministry of Public Health to prohibit selling kratom to additional persons. Sellers must post an announcement at their place of sale (including electronic points of sale) noting the prohibition on selling kratom to these parties. Violating one of these prohibitions or not posting the required announcement or notice is punishable by a fine of up to THB 30,000.

There are two exceptions. Selling to the restricted persons mentioned above may be allowed only if done for medical or educational purposes, defined specifically as follows:

  • Treatment of disease, therapy, or relief of illness under the supervision of a medical practitioner, dental practitioner, Thai traditional medicine practitioner, or traditional medical professional under the law related to the Thai traditional medical profession; or
  • Study, analysis, or research carried out by a government agency that is responsible for conducting medical, pharmaceutical, or scientific research or education, or providing medical, pharmaceutical, or scientific services for the benefit of medical or pharmaceutical, Thai Red Cross Society, or educational institutions.

Besides the prohibitions on selling to certain parties, some locations and points of sale are also off limits for selling kratom leaves or food containing kratom leaves. Kratom leaves by themselves may not be sold in educational institutions, dormitories, parks, zoos, amusement parks, vending machines, or other places specified in announcements by ministers of the Ministry of Justice and the Ministry of Public Health. Violations are subject to a fine of up to THB 50,000—and up to twice that (i.e., THB 100,000) if the sale is to one of the prohibited parties mentioned above.

While consumption of kratom is now legal following its removal from the narcotics list, it is prohibited to consume kratom leaves mixed with narcotic drugs, psychotropic substances, dangerous substances, or any other substance specified by the Ministry of Justice, except when done for the specific medical or education purposes given above. Violation is subject to a maximum fine of THB 50,000.

Advertising

Advertising or promoting the consumption of kratom leaves mixed with narcotics or psychotropic substances, drugs and dangerous substances, or other designated substances is also prohibited under the Kratom Plant Act. This is a comprehensive ban on inducing people to consume any of these kratom-containing mixtures, covering advertisement or any type of marketing communication by means of public relations, news, publishing promotion, point-of-sale displays, direct marketing, sales, and online or computer advertising. Violations of this ban are subject to imprisonment for up to two years, a maximum fine of THB 200,000, or both.

Similarly, convincing others (including “encouraging, deceiving, intimidating, improperly influencing, or forcing”) to consume kratom leaves mixed with narcotic drugs, psychotropic substances, dangerous substances, or other designated substances is also prohibited. Violations of this prohibition are subject to imprisonment for up to one year, a maximum fine of THB 100,000, or both. Penalties can be doubled if the violation is committed against persons under age 18, pregnant or breastfeeding women, or any other person designated by the Ministry of Justice or the Ministry of Public Health, for a maximum sentence of imprisonment for two years and a fine of THB 200,000.

Conclusion

Overall, the Kratom Plant Act lays out a general framework that regulates importing and exporting kratom leaves and supervises the sale, consumption, advertising, and misuse of kratom leaves and food containing kratom leaves. However, there are still additional specific restrictions in various regulations or announcements from the NCB, Ministry of Justice, Ministry of Public Health, and other relevant agencies.

Furthermore, using kratom leaves in certain products can trigger other regulations. For example, using kratom leaves as raw materials or components of herbal products, drugs, and cosmetics may be subject to specific laws such as the Herbal Product Act, Drugs Act, or Cosmetics Act. The relevant provisions under the specific legislation will still apply—even though their restrictions and requirements could differ from those in the Kratom Plant Act.

Consequently, it is advised to seek local expert counsel before starting any business involving kratom, as it is still subject to numerous restrictions and requirements.

Related Professionals

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

June 5, 2026
On May 25, 2026, Vietnam’s Ministry of Health issued Circular No. 16/2026/TT-BYT governing free-of-charge medicine support programs for medical establishments (Circular 16). Circular 16 will take effect on July 10, 2026, replacing Circular No. 31/2018/TT-BYT, which currently regulates the same subject matter. Circular 16 introduces several significant changes compared to the existing legal framework. Removal of Prior Approval Requirement Under the current regulations, free-of-charge medicine support programs are divided into two categories: (1) entirely free-of-charge provision of medicines for all types of drugs and (2) partially free-of-charge provision applicable only to brand-name drugs under patent protection or drugs whose generic products with identical active ingredients and dosage forms are available in Vietnam. Under the current regulations, partially free-of-charge programs are subject to mandatory registration with the competent authority, while entirely free-of-charge programs could be implemented without prior approval. A key reform under Circular 16 is that it stipulates only entirely free-of-charge medicine support programs applicable to all types of medicines, thereby eliminating the partially free-of-charge category. In addition, free-of-charge medicine support programs may be carried out solely based on a written agreement between the pharmaceutical company and the medical establishment, without any requirement for prior approval from competent authorities prior to implementation. Written Agreement Requirements Circular 16 requires the pharmaceutical company and medical establishment to enter into a written agreement in accordance with a prescribed template. This agreement must include the following compulsory information: Information on the supported medicines Form of support (entirely free-of-charge provision to patients) Quantity of medicines provided Target patient groups and applicable indications Duration of the program Rights and obligations of each party Transitional provisions on the protection of patients’ rights upon completion of the program The agreement may contain other contents as agreed by the parties, provided that these do not contradict applicable laws.
Read More
June 4, 2026
Indonesia’s Minister of Health has issued Decree No. HK.01.07/MENKES/301/2026 on the Affixation of Nutritional Labels and Health Information to Ready-to-Eat Processed Food Products. The decree came into force on April 14, 2026, and was issued to implement the Health Law and Minister of Health Regulation No. 3 of 2026 on Disease Control. The decree requires the inclusion of Nutri-Level labeling on the front-of-pack nutrition labeling (FOPNL) to indicate the product’s nutritional level based on the content of sugar, salt, and fat (“gula, garam dan lemak (GGL)”). Changes from 2024 Draft Regulation The Nutri-Level labeling was previously proposed in 2024 by the Indonesian FDA (BPOM) through a draft regulation concerning nutrition information. While the categories of Nutri-Level labeling remain the same in the issued decree, the content requirements of sugar, salt and fat in the decree are different from the earlier proposal introduced in the 2024 draft BPOM regulation. In addition, the decree has further specified that the content of fat in the Nutri-Level labeling is the content of saturated fat, not total fat as previously proposed in the 2024 draft. The decree requires Nutri-Level labeling to be implemented in beverage products, which is the same as previously proposed in the 2024 draft BPOM regulation. Other food products may gradually become subject to mandatory Nutri-Level labeling under future implementing regulations. Nutri-Level Labeling Food levels as shown by the Nutri-Level labeling are classified into four color-coded categories from A to D: Level A (lowest amount) in dark green Level B in light green Level C in yellow Level D (highest amount) in red The Nutri-Level labeling is represented by the following image. The requirements for each level for sugar, salt, and fat content, based on amounts per 100 milliliters of product in beverage form, are as follows. Nutri-Level information must be
Read More
May 29, 2026
Indonesia’s Food and Drug Authority (BPOM) has issued Regulation No. 7 of 2026 on Drug Promotion and Advertising, establishing an updated framework for promotional activities involving medicinal products in Indonesia. The regulation took effect on April 16, 2026, and supersedes BPOM Regulation No. 2 of 2021 on Drug Advertising Supervision. The new regulation maintains general principles for advertising content, including requirements that advertisements be objective, complete, and not misleading, as further detailed in its annex. It also confirms that advertisements for nonprescription drugs directed to the public must obtain prior approval from BPOM before publication and must be in Bahasa Indonesia. The regulation provides a more comprehensive framework governing how drug promotion is conducted, introducing several notable additions and changes, as described below. Procedure and Requirements for Drug Advertisement Approval To apply for a drug advertisement approval, applicants must create an online account through the dedicated portal SIAPIK. Advertisement approval is available only for registered drugs; unregistered drugs are not eligible for advertisement approval with BPOM. The application must include the advertisement design, along with a translation if the design contains any wording in a foreign language. The submission format varies by media type, requiring, for example, copies in the form of print advertisements for visual media, scripts for audio media, and storyboards for audiovisual media. For online media—including social media—submissions should include any captions, descriptions, and hashtags that form an integral part of the advertising material. The approval timeline takes approximately 3–4 months, as BPOM will generally request additional information or revisions during the verification and evaluation process. Applicants have 20 days to submit any such requested documents. BPOM may also conduct a reevaluation of advertisements that have already received approval, based on monitoring results or new information regarding the safety and quality of the advertised drug. This
Read More
May 11, 2026
Vietnam’s legal framework governing chemicals has undergone significant reform, with the Law on Chemicals No. 69/2025/QH15 (Law on Chemicals 2025) taking effect on January 1, 2026. Together with a comprehensive set of implementing instruments issued in January 2026, including three decrees (No. 24/2026/ND‑CP, No. 25/2026/ND‑CP, and No. 26/2026/ND‑CP) and two circulars (No. 01/2026/TT‑BCT and No. 02/2026/TT‑BCT), the Law on Chemicals 2025 has significantly reshaped chemical registration and management requirements. Determining What Constitutes a “New Chemical” Among the most notable changes introduced under the Law on Chemicals 2025 are the rules governing the registration and management of new chemicals, which must be registered with the authority before being placed on the Vietnam market. Although the concept of new chemical registration was first introduced under the Law on Chemicals 2007, the corresponding registration mechanism has remained largely dormant in practice. Under the Law on Chemicals 2025, a “new chemical” is defined as a substance that is not yet included in Vietnam’s National Chemical Inventory and the list of foreign chemical inventories recognized by the competent Vietnamese authority (List of Foreign Chemicals). On a literal reading, the definition in the new law may suggest that a substance qualifies as a new chemical only if it is absent from both lists. Accordingly, a chemical present in either list should be treated as an existing chemical without the registration burden. However, a different interpretation emerges from Decree 26, which specifically requires registration of “new chemicals” even where such substances already appear in the List of Foreign Chemicals. This implies that inclusion in a recognized foreign inventory does not automatically exempt a substance from new chemical registration in Vietnam. This inconsistency between the statutory definition in the Law on Chemicals 2025 and the implementing provisions of Decree 26 creates significant interpretative and compliance challenges. At
Read More